Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Vera Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +22 vs. Q1 2021
- Shares held
- 14.5M
- +14.5M vs. Q1 2021
- Total value
- $186.1M
- +$186.1M vs. Q1 2021
- New holders
- 22
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 28 | $0 | 0.00% | +28 | New |
| BlackRock Inc. | 593 | $8.00K | 0.00% | +593 | New |
| UBS Group AG | 956 | $13.0K | 0.00% | +956 | New |
| Morgan Stanley | 1,784 | $24.0K | 0.00% | +1,784 | New |
| Bank of America Corp | 6,212 | $82.0K | 0.00% | +6,212 | New |
| Goldman Sachs Group Inc | 11,747 | $156.0K | 0.00% | +11,747 | New |
| ExodusPoint Capital Management, LP | 12,841 | $170.0K | 0.00% | +12,841 | New |
| Maven Securities LTD | 13,000 | $178.0K | 0.02% | +13,000 | New |
| Geode Capital Management, LLC | 16,076 | $213.0K | 0.00% | +16,076 | New |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $236.0K | 0.00% | +17,828 | New |
| Caas Capital Management LP | 20,000 | $265.0K | 0.01% | +20,000 | New |
| Monashee Investment Management LLC | 46,069 | $611.0K | 0.07% | +46,069 | New |
| Vanguard Group Inc | 52,268 | $693.0K | 0.00% | +52,268 | New |
| Parkman Healthcare Partners LLC | 75,638 | $1.00M | 0.22% | +75,638 | New |
| Millennium Management LLC | 81,452 | $1.08M | 0.00% | +81,452 | New |
| Alphabet Inc. | 944,791 | $12.5M | 0.26% | +944,791 | New |
| Octagon Capital Advisors LP | 1,132,671 | $15.0M | 3.11% | +1,132,671 | New |
| KPCB XVI Associates, LLC | 1,343,152 | $16.0M | 7.38% | +1,343,152 | New |
| Citadel Advisors LLC | 1,738,693 | $22.2M | 0.02% | +1,738,693 | New |
| FMR LLC | 3,122,512 | $38.5M | 0.00% | +3,122,512 | New |
| Abingworth LLP | 2,960,231 | $38.5M | 11.91% | +2,960,231 | New |
| Sofinnova Investments, Inc. | 2,914,776 | $38.6M | 2.35% | +2,914,776 | New |